As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing star then zero on your touch-tone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Bhavya Shah. Thank you, and over to you, Mr. Shah. Thank you, Renju. Good morning and welcome to the call of Tega Industries Limited to discuss the proposed acquisition of Molycop. Today on the call, we have with us Mr. Mehul Mohanka, Managing Director and Group CEO, and Mr. Sharad Kumar Khetan, Chief Financial Officer. Before we proceed with this call, I would like to give a small disclaimer that this call may contain forward-looking statements which are based on beliefs, opinions, and expectations of the company as of date. Also, we request participants to strictly restrict their questions on the Molycop acquisition. Now, I would like to invite Mr. Mehul Mohanka to initiate the proceedings for the call. Thank you, and over to you, sir. Thank you. Good morning and a warm welcome to all the participants in the call. I'm joined this morning with Sharad Khetan, our CFO. Thank you for joining us today. It's a pleasure to connect with our valued investors, analysts, and stakeholders. We're pleased to announce that Tega Industries, in partnership with the Apollo Funds as a significant minority investor, has entered into a term sheet to acquire Molycop, a leading global supplier in grinding media for the mining industry, from an affiliate of American Industrial Partners, a private equity firm. The transaction is valued at approximately $1.48 billion and is expected to close by December 31, 2025, or early January 2026, subject to regulatory approvals. For Tega, the transaction is proposed to be funded through a mix of equity instruments, including preferential allotment and qualified institutional placements, amounting to $248 million, with a debt infusion in Tega about $112 million. The promoter family plans to take part in the preferential allotment and infuse INR 150-200 crores. We are also open to the idea of changing the mix of debt and equity if so required. The deferred contingent liability is $120 million and will be honored upon the achievement of a certain predefined criteria with a specified timeline. These criteria are primarily linked to the reopening of select closed mines where Molycop was previously a major supplier. This structure ensures that the liability is performance-based and aligned with business upside linked to additional EBITDA from these contracts. If these EBITDA targets are not met, the deferred contingent liability will not get triggered. Molycop is a supplier of grinding media to the mining industry, with a focus on the manufacture and sale of grinding media and chemicals for use in both semi-autogenous grinding mills and ball mills. These products are critical to mineral extraction of multiple minerals, but more specifically, gold and copper. The company's client network covers more than 400 mines in 40 countries. With a history spanning over 100 years, Molycop is recognized for its innovation, scale, and reliability in supporting the mineral processing industry. Apollo Funds is a high-growth global alternative asset manager. For more than three decades, its investing expertise across its fully integrated platform has provided businesses with innovative capital solutions for growth. As of June 2025, Apollo had approximately $840 billion of assets under management, enabling strong financial backing for this transaction. Their deep expertise and scale allows us to confidently execute and fund this strategic acquisition. This strategic complementary acquisition will establish Tega Industries as one of the world's leading designers and manufacturers of critical-to-operate consumables for certain production steps in the mining, mineral processing, and material handling industries, with an innovative and differentiated product portfolio. This acquisition marks a transformational step for significantly strengthening our leadership position in mining consumables. With complementary product portfolios, Tega in polymer mill liners and Molycop in grinding media, we're poised to offer complete mill optimization solutions. A combined presence spans key mining regions across Europe, Middle East, Africa, CIS, Latin America, North America, and Australia. The integration brings together 26 manufacturing sites, enhancing proximity to customers and distribution strength. We expect meaningful revenue and cost synergies, particularly in SG&A and complementary sale of products. Importantly, this transaction will expand EBITDA margins without adding fixed costs while leveraging decades of global relationships. Considering the strong growth potential of the combined business, Tega Industries is expected to deliver a consolidated return on equity of 18%. This reflects our confidence in the strategic fit, operational synergies, and disciplined capital management post-acquisition. Over the next two years, our primary focus will be on seamless integration of businesses. We aim to align organizational structures, harmonize systems, and embed a unified culture across teams. A key priority will be unlocking revenue synergies through complementing opportunities and deeper customer engagement. We will also focus on joint R&D and innovation to enhance our product portfolio. The integration will be executed in phases to ensure business continuity and customer satisfaction. Our goal is to expand EBITDA margins from about the current 11.5% to 15% and deliver long-term value without adding any additional fixed costs. As part of our synergy roadmap, we plan to relocate the current headquarters to a more strategic location with better global access, which is expected to yield cost savings of $7 million. This move has already been discussed with the management teams. We're also targeting a rationalization of selling and general administration expenses by approximately 7%, along with procurement synergies driven by economies of scale. Additionally, the establishment of global capability centers in low-cost locations is projected to generate an additional $5 million in annual savings. Overall, we expect to unlock EBITDA-level synergies of $20 million by year two, scaling up to $30 million annually from year four onwards. These initiatives are aimed at enhancing operational efficiency, margin expansion, and long-term value creation. I'd like to begin by assuring all investors and participants that the debt at Molycop level carries no recourse to Tega Industries. This means our existing business remains fully insulated from any financial uncertainties related to the acquisition, preserving its stability and strength on a standalone basis. Post-acquisition, our focus will be on disciplined financial management to deliver the business over the medium term. We plan to generate strong operating cash flows from the combined entity, supported by expanded margins and cost synergies. A phased reduction in debt will be prioritized, leveraging improved EBITDA performance. Capital expenditure will be optimized to support growth without straining liquidity. We will also explore strategic monetization of non-core assets if needed. Molycop's current debt stands at approximately $1 billion. In partnership with Apollo, our financial investor, we plan to co-invest and bring the debt down to $780 million from day one. This reduction is expected to support an upgrade from our existing credit rating, and over the next four years, we aim to lower our Net Debt-to-EBITDA ratio to less than 2.5 times. The $173 million EBITDA reported in financial year 2025 is going to lead to $50 million of free cash flow after we provide for interest and depreciation. We've actively communicated the roadmap of the acquisition to teams across both Tega and Molycop. The response has been highly encouraging, with employees enthusiastic about the opportunities ahead. While both companies will continue to operate as distinct entities, they will be managed under a coordinated leadership framework to drive synergy and strategic alignment. Talent retention and cross-functional collaboration will be actively supported to preserve institutional knowledge. We will also establish joint governance mechanisms to oversee integration progress. The goal is to build a cohesive, agile organization that leverages the strengths of both entities to deliver enhanced customer value and sustainable growth. Given the diversified global footprint of both Tega and Molycop across multiple regions, we see minimal geopolitical risk exposure. In fact, recent U.S. tariffs are expected to strengthen our position in the U.S. market by creating entry barriers, further supporting the domestic growth and competitiveness. With that, we now open the floor for questions. We welcome your thoughts and are happy to address any queries that you may have. Thank you. We will now begin the question and answer session. Anyone who wishes to ask a question may press star and one on the touch-tone telephone. If you wish to remove yourself from the question queue, you may press star and two. Participants are requested to use handsets while asking a question. Ladies and gentlemen, we'll wait for a moment while the question queue assembles. The first question comes from the line of Renjith with Mahindra Manulife Mutual Fund. Please go ahead. Yeah. Hi, sir. Good morning and congrats on the new acquisition. Sir, I just wanted to understand, when we look at the company that you have acquired, the revenues have been declining for whatever the years which you have given the press release. So what is the reason for that, and how do you see coming back to growth? What's your strategy? And also, does this company have presence in high-chrome grinding media, which is the cast grinding media which Magotteaux or AIA Engineering manufactures? Yeah. If you were to look at the last five-year growth trajectory of Molycop, the years 2021, 2022 financial years were growth years. In 2023, 2024, it tapered primarily due to loss of two major customers due to mine closure and maintenance. As I recently mentioned about the contingent deferred liability, it is linked to the reopening of those mines and those contracts and margins coming back into the business. If I was to normalize the year for those two mines that closed, that's actually been a growth year for them, both 2023 and 2024. As far as the high-chrome cast media strategy, we have a medium to long-term view on high-chrome cast media. We have expanded capacity in Molycop in high-chrome cast media, and the strategy going forward is to monetize the growth in high-chrome in Molycop in different markets across the world. Sir, currently, do they supply high-chrome cast media? Yes. In the last two years, they've been able to increase high-chrome penetration from 0 to 62,000 tons in the past two years, and the aim is to scale to 200,000 tons in the next. Do you serve for primary or secondary grinding? For. Hello? That is for both. Both. Okay. And what's the broad product mix of Molycop, and what is your strategy segment-wise? If you can explain, since you have acquired this, you would have thought about it for the next three, four years, how do you want to scale each segment? That will be helpful. That's the last question from me, sir. Yeah. So as you know, primarily, Molycop is in the forged grinding media business, along with high-chrome, which has been a recent addition to their product portfolio. Today, forged media is the substantial portion of the revenue. And as explained earlier, while the forged media business will grow at about 5%, the addition of the high-chrome strategy will increase the growth rates to about 7.5% over the next three years. Okay. So that means high-chrome, you are expecting double-digit growth. Is that right? That would be correct. Yes. Okay. Okay. That's it from my side, and thanks, and all the best. Thank you. Thank you. Next question comes from the line of Chirag Muchhala with Centrum Broking. Please go ahead. Yeah. Thank you for the opportunity. Sir, the first question is on the margin expansion. So as you are saying that Molycop's margin is planned to increase from the current level of 11% to 15%, it would be a bit helpful if you can also inform about how the historical trends of margin gain in Molycop, as well as some of, I mean, grinding media category in general. And I mean, apart from the two, three leaders that you mentioned, like SG&A, etc., at the gross margin level, where do they operate? And any other integrated relationship, I mean, gross margin relationship leaders that you have for margin expansion at Molycop? Thanks for your question, Chirag. If you see Molycop's past trends, actually, the EBITDA margins have been well higher, and it has been about 14-odd% even in the past, actually. Currently, it's hovering around 11.5%, 12%. Over the next two years, our primary focus shall be on seamless integration of the business, and we aim to align the organizational structures, harmonize systems, and embed a unified culture across the teams. A key priority will be unlocking the revenue synergies through the complementing opportunities and deeper customer engagements. There are a lot of potential for cost synergies as well, like we have mentioned earlier in our call. All of them put together, along with the revenue synergies and the cost synergies, we expect the expansion in the EBITDA margins by about 70 basis points to 100 basis points year on year and take it to about 16%-17% by year five. Okay. And what is the annual depreciation that Molycop will have from the first year of operations under us? Chirag, your voice is not clear. We have not been able to hear you. We'll see. Mr. Muchhala, can you just go ahead, bring your phone closer to you and speak? We cannot hear you. Since we cannot hear Mr. Muchhala, we'll go for the next speaker. Mr. Muchhala, you can just rejoin the queue for more questions. Thank you. Our next question comes from the line of Mayank with Asian Market Securities. Please go ahead. Can you hear me? Yeah, Mayank. Sir, just I think you've given a good slide on the presentation about the product overlap that you are going to have in the merged entity. So could you provide this Molycop consumables or Molycop technology breakdown in the current revenue of Molycop? Currently, the technology and the digital part is a very small portion in the overall Molycop revenue, and that's a key focus and priority area for us, how to increase the share of the digital and technology space in the overall scheme of things. And that's going to be a key driver for us in the revenue synergies. Data analytics, etc., has taken a key prominent space now, and all customers are looking forward to use this data, not only to analyze what has been there, but even to have a preventive maintenance. And that's a key focus and priority area in times to come. So, consumer, and I see one more thing. I mean, basically, in the mineral beneficiation or mineral preparation, mineral preparation side, there is very less presence of Molycop. Is it true? No, it's not like that. Because other equipment, you have not highlighted anything particularly. Molycop is into grinding media. Can you be specific to your question on beneficiation, what do you intend to? I am just trying to understand on the mineral preparation side. If we look at the products that have been highlighted, Molycop is not present. It is present on the mineral beneficiation side, but on the preparation side, it is not present. It's not. Therein your distinction between preparation and beneficiation. I think it is present. Preparation and processing plant. Okay. In the process plant, Molycop is present in the comminution circuit, which is the grinding circuit and the downstream circuit. Okay. Grinding and the downstream circuit. Yeah, location recovery. Primarily, products that have been highlighted are SAG mill, ball mill, and. Yeah. So grinding media is primarily used in grinding mills, and hence, the largest use of Molycop's products is in the grinding mills. Okay. Just one. As is in Tega's cases. Sure. And in the Molycop consumables versus technology, what would be the margin differential? Is there any number? The margins are higher than the technology space. They are almost double in the technology space over the normal cost of products. That part can grow by how much of the revenue categories? What? We are confident that it should grow at least year on year by about 25-odd%. We should be able to grow that business. Sir, who would be your competitors in this space, particularly on the technology side? No one is there as of now. Okay. Thank you. I will get back to you. Thanks, Mayank. Thank you. Next question comes from the line of Varun Jain with Dolat Capital. Please go ahead. Yeah. Hi, sir. So my question is, can you give us a breakup of grinding media capacity for Molycop between forged and high-chrome? And what is the utilization of both of these capacities as of now? So on forged, the capacity is 1.7 million tons. Capacity utilization is at about 70-odd%. In high-chrome, the current capacity is about 20,000 tons, and it's fully utilized. So, you are saying that you want to take this 20,000-200,000 is your target for high-chrome. So, you will be adding close to 180,000 or so of capacity in this? Over a period of time, Molycop currently also, like I mentioned, supplies about 60,000 tons of high-chrome already in the marketplace, and that is done through contracted volumes with sub-vendors. So we could call it as trading volume, and that trading volume will continue to increase alongside capacity expansion of the existing plants. Okay, sir. Got it. And sir, so basically, I saw that Molycop's revenue CAGR over nine years was close to 4%, but EBITDA was close to 1%. So even when it added the high-chrome volumes and such, why was the margins falling? And now, from 11%-15%, what initiatives are you going to take to bring them back up? High-chrome is just a two-year-old strategy. It's just a recent addition starting 2023. Steady-state business of Molycop has actually been growing at about 4.5%-5%, delivering about close to 14% EBITDA already if we normalize that for the mine closure. Last year reported EBITDA was about 11-odd, 12%. It's not 1%. No, no. I was referring to the CAGR of the nine years of EBITDA. And okay. And last question is, this debt on the SPV, it will be a foreign currency borrowing, or it will be from an INR? And what will be the borrowing cost indicative? And will you be funding? Sorry. There's no debt on the SPV. The debt will be on Molycop's books as it is today as well. We're just going to be refinancing the debt in Molycop's books because the change in management control triggers the refinancing. And we expect to get at least 20 to 30 basis points reduction in the interest rate because the leverage will be reduced from $1 billion to $780 million, and the credit rating will also improve subsequently. Okay, sir. Okay. Got it. Thank you, and all the best. Thank you. Thank you. A reminder to all the participants that you may press star and one to ask a question. Next question comes from the line of Srishti Jain with Niveshaay. Please go ahead. Thank you for the opportunity, sir. I just have two questions. Which customer segments or geographies does Molycop help you penetrate or any supply chain efficiencies that can be unblocked with this acquisition for us? And another is, you mentioned proximity with the current customers or the more customers also with Molycop. So in that context, I want to understand how does Molycop's customer list overlap or add to Tega's? Or are there any long-term contracts of Molycop that we can leverage? The Molycop, if you see, it's got a global footprint, and the local closer-to-the-customer strategy helps because the customers want the consumables at shorter notice periods, and considering the current situation, the local manufacturing facilities are more logical, actually. For example, even if you take a U.S. example, Molycop has got its own manufacturing facilities there, and that helps us serve the customers there, and there is no impact of any tariff or regulations or any prohibitions as such. Sir, about the. Sorry. And on the supply chain, there will be efficiencies in terms of procurement. Molycop has a large procurement team which sources materials globally, which Tega can leverage on. On the overlap, I would say every customer of Molycop would be a potential customer of Tega. At this present time, the overlap is not very significant. We have our own set of customers, but the idea would be to bring the complementary nature of both our product lines to the customer so that we can add value in their process efficiency. Can we expect any margin expansion for Tega as well with this acquisition and synergy moving forward? Yes, there will be margin expansion because with increased volumes at no additional fixed cost, the entire gross margins what we generate becomes a pass-through to the EBITDA, which will increase the EBITDA margins. And over and above that, I'll get economies of scale as well. And without any additional fixed cost, there is a significant improvement in the EBITDA margins. Okay. Thank you, sir. Thank you for the opportunity. Thank you. Next question comes from the line of Kirtan Mehta with Baroda BNP Paribas Mutual Fund. Please go ahead. Congratulations, sir, for the transaction. I wanted to understand the challenges which were faced by American Industrial Partners when they hold the stake in Molycop between 2017 and 2024. When they acquired the company, they acquired it around EV of $1.2 billion. Currently, when they are again sort of exiting out of it, it's around $1.5 billion. So probably they have not been able to achieve the targeted improvements in Molycop. So what were those challenges? Could you sort of elaborate on? So American Industrial Partners, we don't perceive that they faced any challenges because during the period of their ownership, they've also been able to extract dividends from the business. We don't know exactly what is the mark on their fund, but we expect that they would have got at least an IRR of anywhere between 13%-14% on this transaction. Today, the business is being sold by AIP because it's reached end of life for them in their fund. So they've held this business for almost close to eight years now, and it's in a fund which is reaching end of life, so they are under compulsion to exit. Right. So I understood. In terms of the cash flow generation-wise, what was the cash flow generation over the last two, three years? So if you see, with the current levels, I bought at an EBITDA of about $170 million. And if you reduce the interest and depreciation as well, you get a free cash flow of about $15 million. If I add back the depreciation, it's about $110 million. Sure. And when we implement our synergies, how would this free cash flow improve over the next three to four years? With the increase in synergies, you have cost savings, you have revenue enhancement, and all of these lead to an improved EBITDA with no additional fixed cost, and that entire gamut flows in as an increase in your free cash flow. Right, and in terms of the CapEx requirements from the Molycop side, when you highlighted about the high-chrome facility where there is a possibility of the capacity expansion, so are there any other areas where we'll have to invest the CapEx? Could you give us some broad idea of what kind of CapEx spend you envisage over the next three, four years? Not a significant amount of CapEx, but about, say, $20-$30 million of CapEx infusion may be required over a period of time, which will be mainly done through the internal accruals there. What is their sustenance CapEx levels? Sustaining CapEx level will be close to about $20 million per year. Right. In terms of the debt-wise, you mentioned that we will be triggering basically some part of the debt repayment. Are you referring to the JPM facility, which was sort of $947 million debt, which was arranged by JPM in November 2024, and there we are looking at a part payment? Yes. Right. And in terms of. It will be low and that is what we are going to refinance. Right. Currently, the EV is around $1.5 billion, where we are contributing around $350 million. Probably Apollo in the similar proportion will contribute around $110 million. So when we are looking to which will together be probably around $500 million. So when we are looking for another $200 million payment out of debt, where would that cash come from? That cash will be infused by Apollo Funds directly into the Molycop as part of the preferential equity to reduce the debt level. Right. So they'll be investing corresponding to our equivalent around 27%, and over and above that, they'll also be infusing preferential equity. Yes. Right. Would it be at the same valuation? It's a preferential shares with a perpetual nature, actually. Right. Thanks for this clarification. I'll get back in the queue. Thank you. A reminder to all the participants, please restrict yourself to two questions. Next question comes from the line of Chirag Muchhala with Centrum Broking. Please go ahead. Yeah. Am I audible now? Yeah, Chirag, you're audible now. Yeah. Sorry. Just two, three follow-up questions. So on this high-chrome that you mentioned, they have 20,000 tons of capacity. So in which country it is? It's in the EMEA region, Chirag. Sorry? It's in the Middle East region. Middle East. Okay. Okay, sir. Secondly, sir, can you give the gross block of this entity, Molycop? It's about $700 million. Okay. And sir, depreciation, like you mentioned in your free cash flow comment, so that would be around $60 million per year. Is that correct? Yeah. $60 million is the depreciation charge. Correct. Okay. Okay, sir. Yeah. Thanks. Thanks for this. Thanks, Chirag. Thank you. Next question comes from the line of Bhalchandra Shinde with Motilal Oswal AMC. Please go ahead. Sir, just two clarifications. Current net debt is around $995 million in Molycop, right? And as you mentioned, that around $110 million kind of cash flows they are generating. Is it free cash flow or operating cash flows? It's an operating cash flow. Operating cash flow. And you saw, sir, saying that Molycop sales actually declined over the last three years. Is it right, or how is the growth trajectory in Molycop? So like we mentioned earlier, for financial year 2021 and 2022, you will see that the growth rates were pretty decent at Molycop. It's because in the last two years, there were certain mines which went into care and maintenance and were closed due to certain political reasons. That is why there's been a dip in the revenue. But with the opening of the mines sector, you will find that uptick coming back and growth getting normalized. Okay. Okay. Okay. Got it. Got it. Got it. Thanks. Thank you. Next question comes from the line of Hitendra Gupta with Systematix Shares & Stocks. Please go ahead. Hey, good morning. First of all, congratulations for this acquisition. I just wanted to understand the whole fundraising thing. So what I understand, Tega would be raising around $248 in equity as well as $113 as a corporate debt. So what would be the total raise? Because I understand the requirement is much higher than this because when somewhere you said in the call that you would be repaying around $220 million, your debt is going to come down from $1 billion to $780 million. So this $220 million, from where will we be funding this? So the equity infusion will be $361 million by Tega, and the remaining will be by Apollo Funds. For the $361 million of equity infusion by Tega, we plan to raise about a debt of $110 million, and the remaining about $250-$260 million will be the fundraise what we intend to do. In our earlier call, we have also mentioned that we are open to recalibrate the levels of debt and equity if required. The debt being repaid at Apollo's level, that is being done through a preferential equity being infused by Apollo directly into the Molycop level. Okay, but that Apollo's $220 million number would. That's an equity participation for the 23% stake they are taking in the entity. Okay. Okay. Okay. It's a $110 number, actually. $110 number. Okay. Thank you. Thank you very much for this. Thank you. Next question comes from the line of Saurabh Ginodia with SMIFS Limited. Please go ahead. Yeah. Good morning, sir, and congratulations for this acquisition. Sir, my first question is with respect to this debt which is sitting on the Molycop balance sheet. Can you give some context whether this debt has come on the book due to some acquisition which Molycop has done in the past? There have been acquisitions by Molycop in the past as well, but there have been dividend payouts, etc., also for which debt was taken at the Molycop level. You mean to say this debt has come due to some big acquisition which Molycop has done in the past, or is there any other reason for this? Acquisitions have definitely been there, Saurabh, and there have also been payouts which led to the increase in debt, and there have been legacy debt also in the Molycop level. Okay. And what would be the reason for this legacy debt? It's acquisition financing operations payout. Okay. So you have given the near-term targets for the debt reduction at the Molycop level. Can you also help us understand what kind of debt level are you looking at for Molycop over the next three to four years? So with the refinancing part, we will bring down the debt level lower down. And as mentioned earlier, we intend to bring it to about net debt-to-EBITDA by about 2.5 times in the three-to-four years period. Okay. And Mehul, you had mentioned in the opening comments regarding non-core asset monetization at the Molycop level. So is it possible for you to quantify what kind of opportunity does he have in terms of non-core asset monetization? We have identified those, Saurabh, but I don't think so at this juncture we would like to give those numbers. Okay. You will not be able to qualify the quantum for this? No, Saurabh. Okay. Just to give some ballpark number, it will be north of $70, $75. Million dollars, you mean to say? Yeah, $75 million. Okay. Okay. And also, just last question, what would be the average EBITDA to PAT conversion for Molycop, let's say, over the last five years? The EBITDA to PAT, if you see, last two, three years, the last year, for example, at the Molycop level, it's almost flat, actually, because after the EBITDA, there was an interest payout and depreciation which has resulted in very low PAT levels at Molycop. It's just we were to see for the last four, five years average. Is it possible for you to just give that number? The last four, five years, if you see, there's also been a lot of restructuring and one-time costs, etc., being taken by Molycop. So it will not be the right way to say it. So on a steady base, if you see, FY25, the last financial year, after the EBITDA and interest payout and the depreciation expenses, it was almost flat. Okay. Okay. Thank you for patiently answering all my questions. Thank you. Thanks, Saurabh. Thank you. Next question comes from the line of Anshul Agrawal with LKP Securities Limited. Please go ahead. Hi, sir. Good morning. Thank you for the opportunity. So, sir, if you could throw some light on the working capital cycle of Molycop and on a blended level with Tega and Molycop consolidated, how do you see it going in the next two, three years? What is your target on that? The working capital cycles at Molycop is about 70-80 odd days, and that's how we want to retain it as of now. Okay, sir, and sir, you said that you are going to decrease the cost of funds by 200 basis points. At the inception level, what's the cost of borrowing at the moment for Molycop? It's about 8.4. Okay. And so you have mentioned about preferential infusing of funds via preferential shares from Apollo's side. So will that be more of a debt-based preferential share, or will that be a convertible wherein Tega's share could come down from 77% to a certain extent? They are simple preferential shares in perpetuity. So they are not convertible preferential shares. Okay, sir. Thank you. Yeah. That's it from my side. Thank you. Next question comes from the line of Ranjith with Mahindra Manulife Mutual Fund. Please go ahead. Yeah. Hi, sir. Just wanted to understand, we generally hear that forged grinding media as a technology is kind of an antique technology, and gradually, high-chrome will take over forged media. So in that perspective, how do you see growth in forged media of Molycop and Tega, which you mentioned? Because what we understand is that the metallurgy, everything is better for a high-chrome grinding media versus a forged media, and gradually, high-chrome will replace forged. That has been the narrative. So how do you expect forged to grow in such a scenario? Just wanted to understand that context. Yeah. So we didn't mention that high-chrome will replace forged. Forged and high-chrome have two distinct applications in the grinding circuit. So we do not see high-chrome cannibalizing forged media at all. Both the businesses, in terms of high-chrome and forged, will have its own growth trajectory. From our perspective, we see high-chrome growing at a faster rate from Molycop because we're coming off a lower base. Forged media is expected to grow at a standard 5-5.5%, while high-chrome will grow at 20% for Molycop. Sir, I didn't mean that we had, but generally, when we go through the transcripts of AIA or Magotteaux, this has been the narrative that both these companies have created the market by cannibalizing on forged. There are certain markets where high-chrome has got greater traction. For example, if you look at Africa and Australia, there has been high-chrome which has been replacing some of these small-sized forged media, small and medium, and recognizing that these particular markets, high-chrome has had a higher conversion rate is why Molycop decided to launch its own high-chrome media, but other than these two markets, we've not seen any pressure of high-chrome in any of the other stronger markets of Molycop, which tend to be the Americas and Europe, and in the larger diameter balls, which is the SAG balls, Molycop has clear leading position. Okay. And, sir, mineral specific is gold, platinum, copper. Specifically, there is the highlight which we see that because you require more high-chrome, this has some properties which gives it more viability in terms of extraction of the ore and other things. So these gold, copper, platinum, are you seeing this conversion more? Is it a mineral-specific thing? Yeah. So for Molycop, almost 83% of its revenues comes from gold and copper. Okay. So largely, your market presence is 100% in SAG mills, and in ball mills is somewhere you believe that there has been some intrusion of high-chrome. Is that the right way to look at it? In certain geographies, the way to negate that is to also supply high-chrome in those markets. Okay. And now we have a facility in Middle East of 20,000 tons, and most of these companies' geographies have put anti-dumping duty, given that Magotteaux has facilities in all these geographies, and that has been hurting the growth prospects of AIA Engineering also. So now you'll be also forced to put up high-chrome facilities in these geographies to address that ADD concerns of most of these geographies? So Molycop already has manufacturing facilities in those geographies, so we would just be expecting. But that is for forged, right? I'm talking about high-chrome. High-chrome, you have only one factory in Middle East. No, we have a factory in Indonesia as well, and there are further capacity expansion in other geographies. So anti-dumping also comes into play if your pricing is considered lower than that of a local manufacturer, but Molycop's strategy has not been to lower the price compared to local players. We've always commanded a premium. But then despite. But despite that premium, your margin is 11%. So I'm able to understand, is it largely to do with the overheads? So why the margins are at 11% while AIA Engineering is at 23%? Yeah. So normalized margins rather than those couple of customers that were lost in 2024 is 15%. There was a reduction in the top line in that year, so that contributes to the reduction in the margin. And we don't see that to be the phenomenon that will carry on from here on. We are going to create cost synergies, which is also going to directly contribute to the margins going forward. Okay, so you said any thought process that you might kind of put towards too many factories, you might think of joining some of these factories together, thereby reducing the overall overheads and that can in a way enable us to improve the margins. Is that one of the strategies that you might be looking at? Too early in the day to comment on that, but if we see that rationalizing the operations contributes to additional incremental EBITDA gains, we would definitely look at that as well. Okay. Okay, sir. Thanks, sir. All the best. Thank you. Ladies and gentlemen, due to time constraints, we have reached the end of question and answer session. I would now like to hand the conference over to the management for closing comments. Thank you, everyone, for participating in the conference call. We welcome your thoughts, and in case if you have any other queries, please reach out to us. We will be happy to answer them. Thank you once again. Thank you. On behalf of Tega Industries Limited, that concludes this conference. Thank you for joining us. You may now disconnect your lines.